Further supporting a key role for hepatic ERα signaling in counteracting NAFLD progression, ERα is poorly expressed in the liver of NASH compared to NAFLD patients [14]. The gene discussed is ESR1; the disease is metabolic dysfunction-associated steatohepatitis.